Actavis: No apologies for seeking Alzheimer's drug profits

NEW YORK (AP) — A lawyer for the Irish manufacturer of an Alzheimer's drug is urging a U.S. appeals court to let it replace a two-pill daily regimen with a single-dose drug even if it cheats generic drugmakers of profits.



via Health News Headlines - Yahoo News http://ift.tt/1Hl4ffU